Author: Geoffrey F. Joyce
Sort By Letter
When Drug Cost-Sharing Increases, Patients Newly Diagnosed with a Chronic Illness Delay Starting Medication
Publication Date: January 2009
Research Area:
Publisher(s): RAND Corporation Author(s): Matthew D. Solomon, Dana P. Goldman, Geoffrey F. Joyce, Jose J. Escarce
Prescription Drug Cost Sharing : A Powerful Policy Lever to Use with Care
Publication Date: January 2009
Research Area:
Modeling the Health and Medical Care Spending of the Future Elderly
Publication Date: January 2008
Research Area:
Publisher(s): RAND Corporation Author(s): Dana P. Goldman, David M. Cutler, Paul G. Shekelle, Jay Bhattacharya, Baoping Shang, Geoffrey F. Joyce, Michael Hurd, Dawn Matsui, Sydne Newberry, Constantijn (Stan) Panis, Michael W. Rich, Catherine K. Su, Emmett B. Keeler, Darius N. Lakdawalla, Michael E. Chernew, Feng Pan, Eduardo Ortiz, Robert H. Brook, A.M. Garber, Shannon Rhodes
A Look inside the "Doughnut Hole": How Drug-Benefit Limits Affect Retiree Prescription Use
Publication Date: January 2007
Research Area: Health
Publisher(s): RAND Corporation Author(s): Geoffrey F. Joyce, Dana P. Goldman, Pinar Karaca-Mandic
A Systematic Review of the Adverse Effects of Prescription Drug Cost Sharing
Publication Date: January 2007
Research Area: Health
Publisher(s): RAND Corporation Author(s): Dana P. Goldman, Geoffrey F. Joyce, Yuhui Zheng
Cutting Drug Co-Payments for Sicker Patients on Cholesterol-Lowering Drugs Could Save a Billion Dollars Every Year
Publication Date: January 2006
Research Area: Health
Publisher(s): RAND Corporation Author(s): Pinar Karaca-Mandic, Geoffrey F. Joyce, Dana P. Goldman